List of works - Giulia Fontemaggi

Absence of in vivo DNA-protein interactions in the DQA2 and DQB2 promoter regions

scientific article

Allelic expression imbalance of TP53 mutated and polymorphic alleles in head and neck tumors

scientific article published on 24 February 2011

Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence.

scientific article published on 21 July 2017

Argonaute 2 sustains the gene expression program driving human monocytic differentiation of acute myeloid leukemia cells.

scientific article

ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promoters.

scientific article

ChIP-on-chip to identify mutant p53 targets

scientific article

Correction: Mutant p53 Enhances Nuclear Factor κB Activation by Tumor Necrosis Factor α in Cancer Cells

scientific article published on 03 September 2015

DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes.

scientific article published in January 2002

Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients

scientific article published on 19 May 2022

Down-regulation of cyclin B1 gene transcription in terminally differentiated skeletal muscle cells is associated with loss of functional CCAAT-binding NF-Y complex

scientific article published on 01 May 1999

Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages.

scientific article published on 19 June 2018

Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients.

scientific article published on 09 October 2013

From p63 to p53 across p73.

scientific article

Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression

scientific article published on March 2015

Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells.

scientific article published on 15 April 2013

Histone-deacetylase 8 drives the immune response and the growth of glioma

scientific article published on 26 July 2021

Id2 gene is a transcriptional target of the protein complex mutant p53/E2F1.

scientific article published on 15 June 2010

Identification of direct p73 target genes combining DNA microarray and chromatin immunoprecipitation analyses.

scientific article

Identification of post-transcriptional regulatory networks during myeloblast-to-monocyte differentiation transition

scientific article

Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells

scientific article

LINC00174 is a novel prognostic factor in thymic epithelial tumors involved in cell migration and lipid metabolism

scientific article published on 07 November 2020

Long Non-coding MIR205HG Depletes Hsa-miR-590-3p Leading to Unrestrained Proliferation in Head and Neck Squamous Cell Carcinoma.

scientific article published on 12 February 2018

Loss of epidermal MCPIP1 is associated with aggressive squamous cell carcinoma

scientific article published in December 2021

MicroRNA expression as predictor of local recurrence risk in oral squamous cell carcinoma.

scientific article published on 24 June 2015

MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function

scientific article

MicroRNAs and lymph node metastatic disease in lung cancer.

scientific article published on 27 December 2011

Modulation of the vitamin D3 response by cancer-associated mutant p53

scientific article

Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells

scientific article published on 01 March 2007

Mutant p53 oncogenic functions are sustained by Plk2 kinase through an autoregulatory feedback loop.

scientific article

Oncogenomic Approaches in Exploring Gain of Function of Mutant p53.

scientific article published on May 2008

Physical and functional interaction between HCV core protein and the different p73 isoforms

scientific article

Physical interaction with human tumor-derived p53 mutants inhibits p63 activities.

scientific article

Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress.

scientific article

S100A2 gene is a direct transcriptional target of p53 homologues during keratinocyte differentiation.

scientific article published on 30 January 2006

The cyclin B1 gene is actively transcribed during mitosis in HeLa cells.

scientific article published on 17 October 2001

The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis.

scientific article published on 27 September 2009

The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1.

scientific article

The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage.

scientific article

The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation

scientific article

Zebrafish as experimental model to establish the contribution of mutant p53 and ID4 to breast cancer angiogenesis in vivo.

scientific article

deltaEF1 repressor controls selectively p53 family members during differentiation.

scientific article published in November 2005

miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours.

scientific article

List of works by Giulia Fontemaggi

Absence of in vivo DNA-protein interactions in the DQA2 and DQB2 promoter regions

Allelic expression imbalance of TP53 mutated and polymorphic alleles in head and neck tumors

Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence.

Argonaute 2 sustains the gene expression program driving human monocytic differentiation of acute myeloid leukemia cells.

ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promoters.

ChIP-on-chip to identify mutant p53 targets

Correction: Mutant p53 Enhances Nuclear Factor κB Activation by Tumor Necrosis Factor α in Cancer Cells

DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes.

Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients

Down-regulation of cyclin B1 gene transcription in terminally differentiated skeletal muscle cells is associated with loss of functional CCAAT-binding NF-Y complex

Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages.

Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients.

From p63 to p53 across p73.

Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression

Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells.

Histone-deacetylase 8 drives the immune response and the growth of glioma

Id2 gene is a transcriptional target of the protein complex mutant p53/E2F1.

Identification of direct p73 target genes combining DNA microarray and chromatin immunoprecipitation analyses.

Identification of post-transcriptional regulatory networks during myeloblast-to-monocyte differentiation transition

Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells

LINC00174 is a novel prognostic factor in thymic epithelial tumors involved in cell migration and lipid metabolism

Long Non-coding MIR205HG Depletes Hsa-miR-590-3p Leading to Unrestrained Proliferation in Head and Neck Squamous Cell Carcinoma.

Loss of epidermal MCPIP1 is associated with aggressive squamous cell carcinoma

MicroRNA expression as predictor of local recurrence risk in oral squamous cell carcinoma.

MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function

MicroRNAs and lymph node metastatic disease in lung cancer.

Modulation of the vitamin D3 response by cancer-associated mutant p53

Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells

Mutant p53 oncogenic functions are sustained by Plk2 kinase through an autoregulatory feedback loop.

Oncogenomic Approaches in Exploring Gain of Function of Mutant p53.

Physical and functional interaction between HCV core protein and the different p73 isoforms

Physical interaction with human tumor-derived p53 mutants inhibits p63 activities.

Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress.

S100A2 gene is a direct transcriptional target of p53 homologues during keratinocyte differentiation.

The cyclin B1 gene is actively transcribed during mitosis in HeLa cells.

The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis.

The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1.

The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage.

The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation

Zebrafish as experimental model to establish the contribution of mutant p53 and ID4 to breast cancer angiogenesis in vivo.

deltaEF1 repressor controls selectively p53 family members during differentiation.

miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours.